Key statistics
On Friday, Innate Pharma SA (IPH:PAR) closed at 1.50, 12.93% above the 52 week low of 1.33 set on Apr 07, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.52 |
---|---|
High | 1.54 |
Low | 1.50 |
Bid | 1.50 |
Offer | 1.51 |
Previous close | 1.51 |
Average volume | 123.08k |
---|---|
Shares outstanding | 92.18m |
Free float | 69.05m |
P/E (TTM) | -- |
Market cap | 138.46m EUR |
EPS (TTM) | -0.61 EUR |
Data delayed at least 15 minutes, as of Jul 11 2025 16:35 BST.
More ▼
- Number of Shares and Voting Rights of Innate Pharma as of July 3, 2025
- Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences
- Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress
- Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences
- Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides
- Outcome of Innate Pharma’s 2025 Annual General Meeting
- Innate Pharma Highlights Abstracts Selected for ASCO 2025 Annual Meeting
- Innate Pharma Highlights ANKET® Abstracts Selected for the EHA 2025 Congress
- Innate Pharma Reports First Quarter 2025 Business Update and Financial Results
- Number of Shares and Voting Rights of Innate Pharma as of May 5, 2025
More ▼